STUDresearch · Peptide
Abaloparatide
Also known as
Tymlos · PTHrP analog · BA058 (development code talk) · abaloparatide 80 mcg
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Systemic daily PTHrP-analog pulse for bone formation.
Subcutaneous prescription pen; follow its product-specific instructions, not click-count shorthand.
Half-life & effect duration
- Half-life in the body
- TymlosAbout 1 hour
- Felt duration people report
- Headache / palpitationsAbout 20 minutes in one account
- Racing heartAbout 45 minutes in another account
- Other accountsNo systemic side effects
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
About 1 hour in the Tymlos label.
This is drug clearance, not how long bone-building benefits last.
Product-specific human PK. Not an estimate for unspecified research vials or a clock for personal symptoms.
- Tymlos prescribing information: pharmacokinetics (opens in a new tab)Section 12.3, Absorption and Excretion: subcutaneous human PK and approximately one-hour half-life.Manufacturer label, not an individual symptom or research-vial study.
Felt duration people report
One person reports headache and palpitations for about 20 minutes; another reports a racing heart for 45 minutes. Others report no systemic side effects.
These are separate experiences, not a standard duration or evidence that the bone effect has worn off.
Uncontrolled patient accounts. Cazzeo's five-minute early back-pain report is a separate person; it does not disprove an older unlocated 45-minute report. Clinical treatment, individual health and recall limit attribution.
- Tymlos: short-lived symptoms in one patient account (opens in a new tab)Outrageous-Tie-9538 comment: headache and palpitations lasting about twenty minutes; insurance interruption discussed separately.One self-report; not a prevalence estimate or proof of causality.
- Tymlos: racing-heart and no-side-effect experiences (opens in a new tab)Comfortable-Self-423: racing heart for 45 minutes. ElReydelTacos and Mme_etoile: no systemic side effects. Cazzeo: early back pain for five minutes.Different people and treatment histories; positive bone-density stories are not acute felt-duration measurements.
Other context in this card
- Tymlos: orthostatic, duration and storage context (opens in a new tab)Tymlos §§2.3, 5.1–5.3, 12.3, 16.2: lifetime-duration recommendation, orthostatic 4 hour window, unknown human osteosarcoma relevance, parent 1 hour half-life and storage. Label text reviewed September 6.Finished prescribed pen; not a validated click-reduction schedule or an individual symptom clock.
- Tymlos: conflicting morning/night reports (opens in a new tab)Separate morning-to-night nausea and night-to-morning insomnia comments; off-label click discussion. Thread text reviewed September 6; no validated alternative dose or preferred time.Different patients and histories; no best hour or proven lower-click efficacy is established.
What people say
- Spine DEXA stories: Same album culture as Forteo — multi-month to two-year T-score jumps, biggest at the spine. forum
- Younger-patient pick: “Adjustable dose and potentially fewer sides” shows up when people in their 40s are choosing a first anabolic. forum
- Then lock it: Same Reclast / Prolia coda as Forteo. forum
- Travel / storage: After first use the pen lives at room temp up to 30 days — the comment that wins vacations vs Forteo’s fridge. trial
- Trial fracture data: ACTIVE-program vertebral-fracture reduction vs placebo is why payers and endos argue it as first anabolic. trial
Doses people talk about
- Do not invent a 20 mcg Tymlos: That number is Forteo. forum
- “Adjustable” talk: Some younger-patient posts say the pen/clinic can adjust. The public Tymlos chart people copy is still 80 mcg. Lower-click reports do not establish a validated efficacy range or an alternative to the labeled 80 mcg daily dose. forum
- Framing: Tymlos pen only in the real logbook — not a compounded mcg menu. forum
- First-use ritual: Fridge until first shot, warm ~30 minutes, then room temp for the 30-day pen life. trial
- Labeled daily: 80 mcg subcutaneous once daily; 30 doses per pen. The pen uses its dose display and product-specific instructions, not a one-click shortcut. trial
- Course: About 18–24 months. Label: do not use more than 2 years over a lifetime in the usual safety language. trial
How it may feel
- Minutes after the pin: Injection-site burn or redness is louder than Forteo in some logs. Dizziness and a brief heart-rate bump show up in the same 30–45 minute window. forum
- Small of the back: One “which injection worked” post: weird low-back pain for ~45 minutes after the shot. forum
- Headache: “I sometimes get a small headache after the injection” is a mild Tymlos baseline. forum
- Weeks 2–8: Nausea / dizzy / mood talk exists but a lot of Tymlos-vs-Forteo posts call Tymlos the milder daily tax. forum
- Hair shed (unlabeled, argued): r/osteoporosis has “losing clumps of hair on Tymlos” threads. Insert does not list it; patients still log it. anecdote
- Months 6–24: Quiet daily habit. Feedback is DEXA and “I didn’t break,” then the what-next drug. forum
Around the dose
- Clock: Daily routines vary. Some posters use morning, others bedtime around symptoms and convenience. forum
- Mixed timing: One poster moved from morning to night because of all-day nausea; another avoided bedtime because of insomnia. Different people, not a controlled comparison. forum
- Separate storage clock: Refrigeration before first use; afterward the label specifies 68–77 °F and a 30 day pen-use limit. trial
Cycles people discuss
- One daily block, then switch class. forum
- Skip-a-vacation-week: Argued. Storage heat >77 °F is the real panic, not a planned off-week. forum
- 30-day pen: Toss leftover at day 30 of room-temp life even if it still sloshes. trial
Timing
- Daily schedule: Tymlos uses a labeled daily schedule; community descriptions call each use a bone-building pulse and missed days missed pulses. Its short parent half-life alone does not establish an appropriate dosing interval or predict the bone response. trialforum
- Serum half-life: About 1 hour (Tymlos label). Same “pulse, not depot” logic as teriparatide. trial
- Room temp after first use: Up to 30 days at 68–77 °F. Fridge before first use. Do not freeze. trial
- Orthostatic window: Tymlos labeling describes dizziness, palpitations, tachycardia or nausea within 4 hours; it specifies a setting where sitting/lying is possible for the first several doses. This is a Tymlos warning, not a Forteo timing rule or felt half-life. trial
More on what it is
- Why people talk about it: r/osteoporosis “Tymlos vs Forteo” is a weekly thread. Travelers want the room-temp pen. Huberman’s bone-peptide line dumps both names into the same search. forum
- Vs Forteo in the rooms: Spine sometimes called a bit stronger on Tymlos; sides “slightly less” in some comparison posts. The storage distinction is refrigeration before first use, then room-temperature storage for up to 30 days under the Tymlos instructions. forumtrial
- Not the same as: Teriparatide 20 mcg. Romosozumab / Evenity monthly. Gray “PTHrP” research vials. forum
- What it is: A synthetic PTHrP analog (not PTH 1-34). Tymlos is the 80 mcg daily pen. Same “anabolic then lock” job as Forteo. trial
- How it works (plain): Hits the PTH1 receptor with a short daily pulse so osteoblasts build. Not an antiresorptive. Not Evenity. trial
- Label job: Osteoporosis at high fracture risk (postmenopausal; men added later). 80 mcg SC once daily. Lifetime >2 years generally not the plan. trial
Stacks
- Calcium / D + lifting — same as Forteo logs. forum
- Follow-on antiresorptive after the course. forum
- Pick Tymlos or Forteo, not both. forum
Storage notes
- No mix chart. forum
- Finished pen. Fridge until first use; then room temp ≤30 days. trial
Watch for
- Injection-site redness / sting: Common. forum
- Dizzy / HR bump / headache / nausea: First-hour and first-month. The label’s orthostatic warning covers symptoms within 4 hours, especially the first several doses; individual accounts also include no systemic symptoms. forum
- Hair clumps: Not on the cute side-effect card; logged anyway. anecdote
- Heat/storage: The pen is refrigerated before first use, then stored at 68–77 °F for up to 30 days, without freezing or excessive heat. Vacation-car overheating remains a patient concern; a brief temperature excursion is not proof that a whole course was ruined. trialforum
- Payer fights: Cigna-denial threads are part of the lived dose — people bounce to Forteo or wait. forum
- Hypercalcemia: Less screamed-about than Forteo, still a label item. trial
- Duration / osteosarcoma context: Use beyond 2 years during a lifetime is not recommended. Rodent osteosarcoma findings have uncertain human relevance; human observational studies have not shown increased risk, but reports exist and data beyond 2 years are limited. The label identifies higher-baseline-risk groups to avoid. trialanimal
